SG11201507240RA - Benzo-fused heterocyclic derivatives useful as agonists of gpr120 - Google Patents
Benzo-fused heterocyclic derivatives useful as agonists of gpr120Info
- Publication number
- SG11201507240RA SG11201507240RA SG11201507240RA SG11201507240RA SG11201507240RA SG 11201507240R A SG11201507240R A SG 11201507240RA SG 11201507240R A SG11201507240R A SG 11201507240RA SG 11201507240R A SG11201507240R A SG 11201507240RA SG 11201507240R A SG11201507240R A SG 11201507240RA
- Authority
- SG
- Singapore
- Prior art keywords
- gpr120
- agonists
- benzo
- fused heterocyclic
- derivatives useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361783118P | 2013-03-14 | 2013-03-14 | |
| PCT/US2014/021790 WO2014159061A2 (en) | 2013-03-14 | 2014-03-07 | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507240RA true SG11201507240RA (en) | 2015-10-29 |
Family
ID=50439484
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507240RA SG11201507240RA (en) | 2013-03-14 | 2014-03-07 | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 |
| SG10201709565QA SG10201709565QA (en) | 2013-03-14 | 2014-03-07 | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201709565QA SG10201709565QA (en) | 2013-03-14 | 2014-03-07 | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US9562053B2 (en) |
| EP (2) | EP2970157B1 (en) |
| JP (2) | JP6479751B2 (en) |
| KR (2) | KR102249047B1 (en) |
| CN (1) | CN105209444B (en) |
| AU (2) | AU2014241397B2 (en) |
| BR (2) | BR112015022290B1 (en) |
| CA (1) | CA2905293C (en) |
| DK (2) | DK3421458T3 (en) |
| EA (1) | EA027781B1 (en) |
| ES (2) | ES2836053T3 (en) |
| IL (2) | IL240643B (en) |
| MX (1) | MX2015012094A (en) |
| NZ (2) | NZ751217A (en) |
| PH (2) | PH12015501941B1 (en) |
| PL (2) | PL3421458T3 (en) |
| SG (2) | SG11201507240RA (en) |
| UA (2) | UA117241C2 (en) |
| WO (1) | WO2014159061A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970157B1 (en) | 2013-03-14 | 2018-04-25 | Janssen Pharmaceutica NV | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 |
| EP3509587B1 (en) | 2016-09-12 | 2023-12-06 | Valo Health, Inc. | Monocyclic compounds useful as gpr120 modulators |
| JP7065081B2 (en) | 2016-09-12 | 2022-05-11 | インテグラル ヘルス， インコーポレイテッド | Bicyclic compounds useful as GPR120 modulators |
| CA3090445A1 (en) | 2018-03-15 | 2019-09-19 | Axxam S.P.A. | Substituted pyrazoles ffa4/gpr120 receptor agonists |
| CN111233724A (en) * | 2020-01-22 | 2020-06-05 | 广东工业大学 | Sulfydryl functionalized organic aromatic carboxylic acid ligand and preparation method and application thereof |
| CN111153841A (en) * | 2020-01-22 | 2020-05-15 | 广东工业大学 | Sulfydryl functionalized organic aromatic carboxylic acid ligand and preparation method and application thereof |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004041266A1 (en) | 2002-11-08 | 2004-05-21 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| EP1585726A1 (en) | 2003-01-06 | 2005-10-19 | Eli Lilly And Company | Fused heterocyclic derivatives as ppar modulators |
| JP4922615B2 (en) * | 2003-11-26 | 2012-04-25 | 武田薬品工業株式会社 | Receptor function regulator |
| US7544707B2 (en) | 2003-12-22 | 2009-06-09 | Eli Lilly And Company | Bicyclic derivatives as PPAR modulators |
| US7456218B2 (en) | 2003-12-25 | 2008-11-25 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
| US7517910B2 (en) | 2004-03-30 | 2009-04-14 | Takeda Pharmaceutical Company Limited | Alkoxyphenylpropanoic acid derivatives |
| WO2008030618A1 (en) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Benzo-fused compounds for use in treating metabolic disorders |
| WO2008030520A1 (en) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Heterocyclic gpr40 modulators |
| WO2008038251A2 (en) | 2006-09-29 | 2008-04-03 | Actelion Pharmaceuticals Ltd | 3-aza-bicyclo[3.1.0]hexane derivatives |
| AU2008218951B2 (en) | 2007-02-22 | 2011-11-17 | Irm Llc | Compounds and methods for modulating g protein-coupled receptors |
| WO2008139987A1 (en) | 2007-04-26 | 2008-11-20 | Japan Science And Technology Agency | G-protein-conjugated receptor agonist |
| WO2009117421A2 (en) | 2008-03-17 | 2009-09-24 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
| MX2011004125A (en) | 2008-10-21 | 2011-05-19 | Metabolex Inc | Aryl gpr120 receptor agonists and uses thereof. |
| AR074760A1 (en) * | 2008-12-18 | 2011-02-09 | Metabolex Inc | GPR120 RECEIVER AGONISTS AND USES OF THE SAME IN MEDICINES FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME. |
| CA2754688A1 (en) * | 2009-03-11 | 2010-09-16 | Msd K.K. | Novel isoindolin-1-one derivative |
| JP5234029B2 (en) * | 2009-08-05 | 2013-07-10 | 山栄化学株式会社 | No-clean active resin composition and surface mounting technology |
| WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| US8299117B2 (en) * | 2010-06-16 | 2012-10-30 | Metabolex Inc. | GPR120 receptor agonists and uses thereof |
| WO2011159297A1 (en) * | 2010-06-16 | 2011-12-22 | Metabolex, Inc. | Gpr120 receptor agonists and uses thereof |
| EP2747560A4 (en) | 2011-07-29 | 2015-02-25 | Tempero Pharmaceuticals Inc | Compounds and methods |
| EP2970157B1 (en) | 2013-03-14 | 2018-04-25 | Janssen Pharmaceutica NV | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 |
-
2014
- 2014-03-07 EP EP14715479.3A patent/EP2970157B1/en active Active
- 2014-03-07 SG SG11201507240RA patent/SG11201507240RA/en unknown
- 2014-03-07 ES ES18169050T patent/ES2836053T3/en active Active
- 2014-03-07 US US14/200,093 patent/US9562053B2/en active Active
- 2014-03-07 JP JP2016500852A patent/JP6479751B2/en active Active
- 2014-03-07 ES ES14715479.3T patent/ES2673921T3/en active Active
- 2014-03-07 CN CN201480027554.9A patent/CN105209444B/en active Active
- 2014-03-07 PL PL18169050T patent/PL3421458T3/en unknown
- 2014-03-07 KR KR1020157029093A patent/KR102249047B1/en active IP Right Grant
- 2014-03-07 NZ NZ751217A patent/NZ751217A/en unknown
- 2014-03-07 PL PL14715479T patent/PL2970157T3/en unknown
- 2014-03-07 UA UAA201510004A patent/UA117241C2/en unknown
- 2014-03-07 DK DK18169050.4T patent/DK3421458T3/en active
- 2014-03-07 EP EP18169050.4A patent/EP3421458B1/en active Active
- 2014-03-07 SG SG10201709565QA patent/SG10201709565QA/en unknown
- 2014-03-07 AU AU2014241397A patent/AU2014241397B2/en active Active
- 2014-03-07 WO PCT/US2014/021790 patent/WO2014159061A2/en active Application Filing
- 2014-03-07 UA UAA201802291A patent/UA123269C2/en unknown
- 2014-03-07 EA EA201591734A patent/EA027781B1/en active IP Right Revival
- 2014-03-07 MX MX2015012094A patent/MX2015012094A/en active IP Right Grant
- 2014-03-07 NZ NZ711191A patent/NZ711191A/en unknown
- 2014-03-07 KR KR1020217013150A patent/KR102422559B1/en active IP Right Grant
- 2014-03-07 BR BR112015022290-0A patent/BR112015022290B1/en active IP Right Grant
- 2014-03-07 BR BR122021021616-9A patent/BR122021021616B1/en active IP Right Grant
- 2014-03-07 CA CA2905293A patent/CA2905293C/en active Active
- 2014-03-07 DK DK14715479.3T patent/DK2970157T3/en active
-
2015
- 2015-08-18 IL IL240643A patent/IL240643B/en active IP Right Grant
- 2015-09-03 PH PH12015501941A patent/PH12015501941B1/en unknown
-
2016
- 2016-12-08 US US15/372,884 patent/US10155737B2/en active Active
-
2018
- 2018-08-08 AU AU2018214053A patent/AU2018214053B2/en active Active
- 2018-11-19 US US16/195,553 patent/US10730847B2/en active Active
-
2019
- 2019-02-06 JP JP2019019370A patent/JP6802302B2/en active Active
- 2019-03-04 PH PH12019500467A patent/PH12019500467A1/en unknown
- 2019-06-10 IL IL267196A patent/IL267196B/en active IP Right Grant
-
2020
- 2020-06-19 US US16/907,118 patent/US11254647B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267196B (en) | Benzo-fused heterocyclic derivatives useful as agonists of gpr120 | |
| HRP20181710T1 (en) | Use of benzimidazole-proline derivatives | |
| EP2982666A4 (en) | Heterocyclic compound | |
| EP3013796A4 (en) | Biaryl derivatives as gpr120 agonists | |
| AP2016009176A0 (en) | Novel heterocyclic compounds | |
| EP3018126A4 (en) | Heterocyclic compound | |
| IL245443A0 (en) | Substituted pyridine derivatives useful as gsk-3 inhibitors | |
| ZA201602198B (en) | Preparation of hydroxy-benzylbenzene derivatives | |
| EP2980089A4 (en) | Heterocyclic compound | |
| HRP20190133T1 (en) | Heterocyclic compound | |
| EP2961403A4 (en) | Heterocyclic inhibitors of the sodium channel | |
| EP2982670A4 (en) | Heterocyclic compound | |
| EP2914580A4 (en) | Thioaryl derivatives as gpr120 agonists | |
| IL240763A0 (en) | Halogenopyrazoles as inhibitors of therombin | |
| GB201314960D0 (en) | Heterocyclic derivatives | |
| GB201300306D0 (en) | Heterocyclic derivatives | |
| TH1501003198A (en) | Heterocyclic compounds |